RecombinantBiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling),hFcTag性能參數分子別名（Synonyms）OX40Lreceptor;CD134;TNFRSF4;Ly-70表達區間及表達系統（Source）BiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling)isexpressedfromHEK293withhFctagattheC-Terminus.ItcontainsLeu29-Ala216.[Accession|P43489]分子量大小（MolecularWeight）TheproteinhasapredictedMWof46.8kDa.Duetoglycosylation,theproteinmigratesto72-75kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGE制劑（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).儲存條件Theproductshouldbestoredat-85~-65℃for1yearfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.RANTES是CC趨化因子，可以通過CCR1，CCR3，CCR5和US28（巨細胞病毒受體）受體發出信號。Recombinant Human CD300LF Protein,hFc Tag

SARS-CoV-2,whichcausestheglobalpandemiccoronavirusdisease2019(Covid-19),belongstoafamilyofvirusesknownascoronaviruses.TheSARS-CoV-2Sproteinisaglycoproteinthatmediatesmembranefusionandviralentry.TheRBDofSARS-CoV-2bindsametallopeptidase,angiotensin-convertingenzyme2(ACE-2).SeveralemergingSARS-CoV-2genomeshavebeenidentifiedincludingtheOmicron,orB.1.1.529,variant.FirstidentifiedinNovember2021inSouthAfrica,theOmicronvariantquicklybecamethepredominantSARS-CoV-2variantandisconsideredavariantofconcern(VOC).TheOmicronvariantcontains15mutationsinRBDdomainthatpotentiallyaffectviralfitnessandtransmissibility.ThemajorityofthemutationsareinvolvedinACE-2bindingandOmicronbindsACE-2withgreateraffinity,potentiallyexplainingitsincreasedtransmissibility.Severalofthesemutationsarealsoidentifiedinfacilitatingimmuneescapeandreducingneutralizationactivitytoseveralmonoclonalantibodies.Recombinant Human RGMa Protein,His-Avi Tag成纖維細胞生長因子18（FGF-18）是20 kDa蛋白，在骨骼發育和骨穩態中起著重要作用。

CD40,alsoknownasTNFRSF5,isa45-50kDatypeItransmembraneglycoproteinmemberoftheTNFreceptorsuperfamily.MaturehumanCD40consistsofa173aminoacid(aa)extracellulardomain,atransmembranedomain,anda62aacytoplasmicdomain.CD40servesmultiplefunctionsinbothhematopoieticandepithelialcancersandisatargetfortumorimmunotherapy.DysregulationofCD40/CD40LigandexpressionandinteractionscontributestotheimmunedeficiencyassociatedwithHIVinfectionandAIDS.Itisalsoimplicatedinthepathologyofmultiplecardiovasculardiseasesincludingatherosclerosis,atherothrombosis,andrestenosis.產品性質別名CD40;CD40Lreceptor;TNFRSF5;CD40antigen;CD40molecule;CDw40;MGC9013;UniprotNo.P25942表達區間及表達系統RecombinantBiotinylatedHumanCD40/TNFRSF5ProteinisexpressedfromHEK293CellswithHistagandAvitagattheC-terminal.ItcontainsGlu21-Arg193.分子量Approximately22.1kDa.Duetoglycosylation,theproteinmigratesto35-40kDabasedonTris-BisPAGEresult.純度>95%asdeterminedbySDS-PAGEandHPLC.活性

N-糖苷酶F(PNGaseF)酶活定義（UnitDefinition）1個酶活力單位指在10μL的反應體系中，37℃條件下1小時從10μg變性RNaseB中除去超過95%的碳水化合物所需要的酶量。儲存條件-15~-25℃保存，有效期1年。使用說明變性條件下蛋白質去糖基化1）在水中加入1μLBuffer1和目標糖蛋白（1-20μg），至終體積10μL；2）100℃溫度下煮沸10min使其變性，冰上冷卻，離心10秒；3）加入2μL的Buffer2、2μL的10％NP-40、6μL去離子水，總反應體積20μL；4）加入0.2~0.5μL的PNGase，輕輕混勻。在37℃孵育1-3h。非變性條件下蛋白質去糖基化1）在水中加入2μL的Buffer2和目標糖蛋白（1-20μg）至體積為20μL。2）加入0.5~1μL的PNGaseF,輕輕混勻。3）37°C孵育4-24h。注意：在變性條件下大多數底物能夠更好的去糖基化，在非變性條件下可能需要增加PNGaseF的量和延長孵育時間。26Rfa, Hypothalamic Peptide, human，純度：經SDS-PAGE和HPLC鑒定純度大于98%。

RecombinantHumanACE2/ACEHProtein,hFcTag性能參數，分子別名（Synonyms）ACE2;ACEH;ACE-2表達區間及表達系統（Source）HumanACE2/ACEHProteinisexpressedfromHEK293withhFctagattheC-Terminus.ItcontainsGln18-Ser740.[Accession|Q9BYF1-1]分子量大小（MolecularWeight）TheproteinhasapredictedMWof109.2kDa.Duetoglycosylation,theproteinmigratesto115-130kDabasedonSDS-PAGEresult.Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGEandHPLC.活性（Activity）ELISAData:ImmobilizedSARS-COV-2SpikeS(B.1.1.529/Omicron)Trimer,HisTagat1μg/ml(100μl/well)ontheplate.DoseresponsecurveforHumanACE2,hFcTagwiththeEC50of13.7ng/mldeterminedbyELISA.制劑（Formulation）Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重構方法（Reconstitution）Centrifugethetubebeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.UbcH5a/UBE2D1具有一個保守的E2催化結構域，該結構域含有一個活性位點半胱氨酸殘基。Recombinant Rat PDGF R beta/CD140b Protein,His Tag

CX3CL1受到促炎性刺激的上調，包括巨噬細胞，樹突狀細胞，內皮細胞，神經元，平滑肌，上皮細胞的細胞類型。Recombinant Human CD300LF Protein,hFc Tag

產品性質英文別名（EnglishSynonym）Factor-1CAS號（CASNO.）9001-32-5外觀（Appearance）白色至類白色凍干粉末或塊狀物蛋白含量（ProteinContent）50-70%protein（(≥85%ofproteinisclottable)溶解性（Solubility）溶于0.9%生理鹽水（10mg/ml），不溶于水運輸和保存方法冰袋運輸。-20℃保存，有效期4年。注意事項1）纖維蛋白原一般應采用37℃的生理鹽水溶解，溶解時溫度不宜過低，在4℃條件下以及不含鹽的溶液中難以溶解。注意纖維蛋白原溶液在50℃以上變性，因此加熱溫度不宜超過50℃。2）為了您的安全和健康，請穿實驗服并戴一次性手套操作。3）本產品作科研用途！儲存液配制牛纖維蛋白原可溶于0.9%NaCl溶液，配制成2.5-10mg/ml的溶液于-20℃凍存，無菌過濾后可穩定保存約1周。注：①溶解時將本品緩慢置于37℃預熱的生理鹽水，可輕輕攪動使其慢慢溶解，不可旋渦震蕩！②過濾時建議用0.2μm濾膜過濾，不可用0.1μm濾膜。可使用注射器緩慢過濾，不可用真空過濾。Recombinant Human CD300LF Protein,hFc Tag